154 related articles for article (PubMed ID: 3858662)
1. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D
Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a K562 cell line resistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction.
Biancha Scarrà G; Fiorentini P; Gambari R; Nastruzzi C; Barbieri R; Sessarego M; Ravazzolo R; Garrè C
Exp Hematol; 1989 Sep; 17(8):859-64. PubMed ID: 2475359
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of ras protooncogenes during in vitro differentiation of human erythroleukemia cells.
Delgado MD; Quincoces AF; Gómez-Casares MT; Martínez CA; Cuadrado MA; Richard C; León J
Cancer Res; 1992 Nov; 52(21):5979-84. PubMed ID: 1394224
[TBL] [Abstract][Full Text] [Related]
4. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
Kharbanda S; Emoto Y; Kisaki H; Saleem A; Kufe D
Mol Pharmacol; 1994 Jul; 46(1):67-72. PubMed ID: 8058058
[TBL] [Abstract][Full Text] [Related]
5. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
[TBL] [Abstract][Full Text] [Related]
7. Positive and negative regulation of specific gene expression by the tumor promoter TPA in human erythroleukemic K562 cells.
Siebert PD; Fukuda M
Prog Clin Biol Res; 1985; 191():233-48. PubMed ID: 3863149
[TBL] [Abstract][Full Text] [Related]
8. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
9. Tumor-promoting phorbol diester-induced specific changes in cell surface glycoprotein profile of K562 human leukemic cells.
Fukuda M
Cancer Res; 1981 Nov; 41(11 Pt 1):4621-8. PubMed ID: 7306980
[TBL] [Abstract][Full Text] [Related]
10. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
Honma Y; Onozuka Y; Okabe-Kado J; Kasukabe T; Hozumi M
Cancer Res; 1991 Sep; 51(17):4535-8. PubMed ID: 1873797
[TBL] [Abstract][Full Text] [Related]
11. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
Tonini GP; Radzioch D; Gronberg A; Clayton M; Blasi E; Benetton G; Varesio L
Cancer Res; 1987 Sep; 47(17):4544-7. PubMed ID: 3476195
[TBL] [Abstract][Full Text] [Related]
12. Phorbol ester tumor promoters block the transition from the early to the heme-dependent late program of Friend cell differentiation.
Mager D; Bernstein A
J Cell Physiol; 1980 Dec; 105(3):519-26. PubMed ID: 6936401
[TBL] [Abstract][Full Text] [Related]
13. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
14. Requirement of spermidine for induction of both heme synthesis and globin transcription in murine erythroleukemia cells.
Watanabe T; Shafman T; Kufe DW
J Cell Physiol; 1985 Mar; 122(3):435-40. PubMed ID: 3918047
[TBL] [Abstract][Full Text] [Related]
15. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
[TBL] [Abstract][Full Text] [Related]
16. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate: biochemical, physical, and morphological characterization.
Nagasawa K; Howatson A; Mak TW
J Cell Physiol; 1981 Oct; 109(1):181-92. PubMed ID: 6976970
[TBL] [Abstract][Full Text] [Related]
17. Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
Fibach E; Gambari R; Shaw PA; Maniatis G; Reuben RC; Sassa S; Rifkind RA; Marks PA
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1906-10. PubMed ID: 287029
[TBL] [Abstract][Full Text] [Related]
18. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
Henschler R; Brennscheidt U; Mertelsmann R; Herrmann F
Mol Pharmacol; 1991 Feb; 39(2):171-6. PubMed ID: 1996082
[TBL] [Abstract][Full Text] [Related]
19. Effects of 1-beta-D-arabinofuranosylcytosine on proto-oncogene expression in human U-937 cells.
Mitchell T; Sariban E; Kufe D
Mol Pharmacol; 1986 Oct; 30(4):398-402. PubMed ID: 3531806
[TBL] [Abstract][Full Text] [Related]
20. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product.
Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F
J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
